Correlation Between Equillium and Biomarin Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Equillium and Biomarin Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Biomarin Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Equillium and Biomarin Pharmaceutical, you can compare the effects of market volatilities on Equillium and Biomarin Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Biomarin Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Biomarin Pharmaceutical.
Diversification Opportunities for Equillium and Biomarin Pharmaceutical
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Equillium and Biomarin is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Biomarin Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomarin Pharmaceutical and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Biomarin Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomarin Pharmaceutical has no effect on the direction of Equillium i.e., Equillium and Biomarin Pharmaceutical go up and down completely randomly.
Pair Corralation between Equillium and Biomarin Pharmaceutical
Allowing for the 90-day total investment horizon Equillium is expected to under-perform the Biomarin Pharmaceutical. In addition to that, Equillium is 1.98 times more volatile than Biomarin Pharmaceutical. It trades about -0.23 of its total potential returns per unit of risk. Biomarin Pharmaceutical is currently generating about -0.12 per unit of volatility. If you would invest 6,649 in Biomarin Pharmaceutical on November 2, 2024 and sell it today you would lose (261.00) from holding Biomarin Pharmaceutical or give up 3.93% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Equillium vs. Biomarin Pharmaceutical
Performance |
| Timeline |
| Equillium |
| Biomarin Pharmaceutical |
Equillium and Biomarin Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Equillium and Biomarin Pharmaceutical
The main advantage of trading using opposite Equillium and Biomarin Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Biomarin Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomarin Pharmaceutical will offset losses from the drop in Biomarin Pharmaceutical's long position.| Equillium vs. Lyra Therapeutics | Equillium vs. Hookipa Pharma | Equillium vs. Jasper Therapeutics | Equillium vs. Cingulate Warrants |
| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |